Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?

PURPOSE: The present study aims to conduct a systematic review of literature reporting on the dose and dosing schedule of dexamethasone (DXM) in relation to clinical outcomes in malignant brain tumor patients, with particular attention to evidence-based practice. METHODS: A systematic search was per...

Descripción completa

Detalles Bibliográficos
Autores principales: Jessurun, Charissa A. C., Hulsbergen, Alexander F. C., Cho, Logan D., Aglio, Linda S., Nandoe Tewarie, Rishi D. S., Broekman, Marike L. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Topic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700052/
https://www.ncbi.nlm.nih.gov/pubmed/31346902
http://dx.doi.org/10.1007/s11060-019-03238-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700052/
https://www.ncbi.nlm.nih.gov/pubmed/31346902
http://dx.doi.org/10.1007/s11060-019-03238-4

Ejemplares similares